HECCTOR 2025挑战赛构建多模态影像基准,提升头颈癌自动分割与预后预测能力。
HEad and neCK TumOR (HECKTOR) 2025: Benchmark of Segmentation, Diagnosis, and Prognosis in Multimodal PET/CT

- 基于10家医院1100+患者数据,用PET/CT与电子病历进行肿瘤分割、生存预测和HPV分类
- 最佳模型分割准确率(Dice)达0.75,生存预测一致性指数为0.66,HPV分类平衡准确率0.56
- 推动放射治疗自动化,适合医学影像与临床决策研究者参考
头颈部癌症(HNC)是全球重大健康负担,精准肿瘤勾画对放疗规划至关重要。由于口咽部解剖复杂且肿瘤影像表现异质,手动分割耗时且存在观察者差异。除分割外,从非侵入性影像中预测复发无病生存期(RFS)及判断人乳头瘤病毒(HPV)状态仍具挑战但临床价值高。HECKTOR 2025挑战赛通过多模态PET/CT与电子健康记录建立头颈癌自动分析综合基准。延续2020–2022年版本,本年度数据集覆盖超1,100名患者,来自全球10个机构。参赛团队需完成三项互补任务:(1)勾画原发肿瘤体积(GTVp)与转移淋巴结(GTVn);(2)预测复发无病生存期;(3)分类HPV状态。共35支队伍注册,15支提交最终结果,在保留测试集上评估。最优算法在分割任务中平均Dice系数达0.75,生存预测的协和指数为0.66,HPV分类平衡准确率为0.56。本文系统分析参赛方法,评估其在不同病灶特征下的表现,并探讨其在自动化肿瘤学工作流与辅助决策系统中的临床转化意义。
原文摘要 · Abstract (English)
Head and neck cancers (HNC) represent a significant global health burden, with accurate tumor delineation being essential for effective radiotherapy planning. The complexity of the oropharyngeal anatomy, combined with the heterogeneous appearance of tumors on imaging, makes manual segmentation time-intensive and subject to inter-observer variability. Beyond segmentation, predicting long-term clinical outcomes, such as recurrence-free survival (RFS), and determining human papillomavirus (HPV) status from noninvasive imaging, remain challenging yet clinically valuable goals. The HECKTOR 2025 challenge addresses these needs by establishing a comprehensive benchmark for automated HNC analysis using multimodal PET/CT imaging and electronic health records. Building on previous editions (2020-2022), this challenge features an expanded multi-institutional dataset comprising over 1,100 patients from 10 centers worldwide. Participants were tasked with three complementary objectives: (1) segmenting primary gross tumor volumes (GTVp) and metastatic lymph nodes (GTVn), (2) predicting recurrence-free survival, and (3) classifying HPV status. The challenge attracted 35 registered teams, with 15 final submissions evaluated on a held-out test set. Top-performing algorithms achieved a mean Dice similarity coefficient of 0.75 for segmentation, a concordance index of 0.66 for survival prediction, and a balanced accuracy of 0.56 for HPV classification. This paper presents a comprehensive analysis of the submitted methodologies, evaluates their performance across different lesion characteristics, and discusses their implications for clinical translation in automated oncology workflows and decision support systems.
Thank you to arXiv for use of its open access interoperability. PaperDance 不是 arXiv 官方产品;中文卡片由大模型生成,请以原文为准。